BIOMARIN PHARMACEUTICAL INC Patent Applications Rejected
49 applications abandoned without a patent; the status gives the reason, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.
- 2024-06-28: Application 18759454; Invention Targeted Therapeutic Lysosomal Enzyme Fusion Proteins and Uses Thereof; Applicant BioMarin Pharmaceutical Inc.; Status Abandoned -- Incomplete Application (Pre-examination).
- 2024-05-28: Application 18676309; Invention ADENO-ASSOCIATED VIRUS CAPSID PROTEINS; Applicant BIOMARIN PHARMACEUTICAL INC.; Status Abandoned -- Incomplete Application (Pre-examination).
- 2024-05-13: Application 18662491; Invention STABLE EXPRESSION OF AAV VECTORS IN JUVENILE SUBJECTS; Applicant BIOMARIN PHARMACEUTICAL INC.; Status Abandoned -- Incomplete Application (Pre-examination).
- 2024-04-01: Application 18697587; Invention TREATMENT OF HEREDITARY ANGIOEDEMA WITH AAV GENE THERAPY VECTORS AND THERAPEUTIC FORMULATIONS; Applicant BIOMARIN PHARMACEUTICAL INC.; Status Abandoned -- Incomplete Application (Pre-examination).
| Filed | Application | Invention | Applicant | Status | Published as | Inventor name | Inventor country | Examiner |
|---|---|---|---|---|---|---|---|---|
| 2024-06-28 | 18759454 | Targeted Therapeutic Lysosomal Enzyme Fusion Proteins and Uses Thereof | BioMarin Pharmaceutical Inc. | Abandoned -- Incomplete Application (Pre-examination) | Mika Aoyagi-Scharber Teresa Margaret Christianson Melita Dvorak-Ewell Daniel J. Wendt Shinong Long Jonathan LeBowitz Daniel Solomon Gold | United States United States United States United States United States United States United States | ||
| 2024-05-28 | 18676309 | ADENO-ASSOCIATED VIRUS CAPSID PROTEINS | BIOMARIN PHARMACEUTICAL INC. | Abandoned -- Incomplete Application (Pre-examination) | US20240317813A1 | Peter Cameron COLOSI Michael LOCHRIE Robert NG | United States United States United States | |
| 2024-05-13 | 18662491 | STABLE EXPRESSION OF AAV VECTORS IN JUVENILE SUBJECTS | BIOMARIN PHARMACEUTICAL INC. | Abandoned -- Incomplete Application (Pre-examination) | US20240285806A1 | Stuart BUNTING | United States | |
| 2024-04-01 | 18697587 | TREATMENT OF HEREDITARY ANGIOEDEMA WITH AAV GENE THERAPY VECTORS AND THERAPEUTIC FORMULATIONS | BIOMARIN PHARMACEUTICAL INC. | Abandoned -- Incomplete Application (Pre-examination) | US20240408240A1 | Peter COLOSI JooChaun ANG Saeed MOSHASHAEE Stephanie VARGAS Thomas MACHING Jack BROWNRIGG Lawrence Mason SHIH Iris CHEN Heather Ann WENZEL | United States United States United States United States United States United States United States United States United States | |
| 2024-03-01 | 18688691 | AAV CAPSID COMPOSITIONS AND METHODS FOR DELIVERY | BIOMARIN PHARMACEUTICAL INC. | Abandoned -- Incomplete Application (Pre-examination) | US20240384242A1 | Peter COLOSI Vincent LEONARD Silvia RAMIREZ Justin ISHIDA Yu-Shan TSENG Teague STERLING | United States United States United States United States United States United States | |
| 2024-03-01 | 18688688 | AAV CAPSID COMPOSITIONS AND METHODS FOR DELIVERY | BIOMARIN PHARMACEUTICAL INC. | Abandoned -- Incomplete Application (Pre-examination) | US20250122530A1 | Peter COLOSI Vincent LEONARD Silvia RAMIREZ Justin ISHIDA Yu-Shan TSENG Teague STERLING | United States United States United States United States United States United States | |
| 2024-03-01 | 18688685 | AAV CAPSID COMPOSITIONS AND METHODS FOR DELIVERY | BIOMARIN PHARMACEUTICAL INC. | Abandoned -- Incomplete Application (Pre-examination) | US20240376496A1 | Peter COLOSI Vincent LEONARD Silvia RAMIREZ Justin ISHIDA Yu-Shan TSENG Teague STERLING | United States United States United States United States United States United States | |
| 2024-03-01 | 18688682 | AAV CAPSID COMPOSITIONS AND METHODS FOR DELIVERY | BIOMARIN PHARMACEUTICAL INC. | Abandoned -- Incomplete Application (Pre-examination) | US20240376495A1 | Peter COLOSI Vincent LEONARD Silvia RAMIREZ Justin ISHIDA Yu-Shan TSENG Teague STERLING | United States United States United States United States United States United States | |
| 2023-11-07 | 18503593 | Targeted Therapeutic Lysosomal Enzyme Fusion Proteins and Uses Thereof | BioMarin Pharmaceutical Inc. | Abandoned -- Incomplete Application (Pre-examination) | Mika Aoyagi-Scharber Teresa Margaret Christianson Melita Dvorak-Ewell Daniel J. Wendt Shinong Long Jonathan LeBowitz Daniel Solomon Gold | United States United States United States United States United States United States United States | ||
| 2023-10-02 | 18479761 | METHODS OF REDOSING GENE THERAPY VECTORS | BIOMARIN PHARMACEUTICAL INC. | Abandoned -- Failure to Respond to an Office Action | US20240200096A1 | Peter COLOSI Justin ISHIDA Silvia RAMIREZ | United States United States United States | SALVOZA, M FRANCO G |
| 2023-08-14 | 18277141 | USE OF HISTIDINE RICH PEPTIDES AS A TRANSFECTION REAGENT FOR rAAV AND rBV PRODUCTION | BioMarin Pharmaceutical Inc. | Abandoned -- Failure to Respond to an Office Action | US20240132910A1 | Irina PEREVOSHCHIKOVA Baran ARSLAN Julie GARDIN Pauline BOURBON Helai ARABSHAHI Tomas CINEK Shilpa SHROFF | United States United States United States United States United States United States United States | WILSON, MICHAEL C |
| 2022-12-08 | 18063589 | NOVEL ADENO-ASSOCIATED VIRUS CAPSID PROTEINS | BIOMARIN PHARMACEUTICAL INC. | Abandoned -- Failure to Respond to an Office Action | US20230322864A1 | Peter Cameron COLOSI Michael LOCHRIE Robert NG | United States United States United States | GRABER, JAMES J |
| 2022-10-19 | 18047824 | COMPOSITIONS OF PROKARYOTIC PHENYLALANINE AMMONIA-LYASE VARIANTS AND METHODS OF USING COMPOSITIONS THEREOF | BIOMARIN PHARMACEUTICAL INC. | Abandoned -- Failure to Respond to an Office Action | US20240035013A1 | Augustus O. OKHAMAFE Sean M. BELL G. Nick ZECHERLE Kris ANTONSEN Yanhong ZHANG Kieu Ly TRAN Paul A. FITZPATRICK Emil D. KAKKIS Michel Claude VELLARD Daniel J. WENDT Mubarack MUTHALIF | United States United States United States United States United States United States United States United States United States United States United States | PAK, YONG D |
| 2022-08-05 | 17760227 | VIRUS-FREE CELL CULTURES | BIOMARIN PHARMACEUTICAL INC. | Abandoned -- Failure to Respond to an Office Action | US20230075854A1 | Michael LOCHRIE Peter COLOSI Barrie CARTER Tomas CINEK | United States United States United States United States | WANG, RUIXUE |
| 2022-07-27 | 17815468 | Lysosomal Targeting Peptides and Uses Thereof | BIOMARIN PHARMACEUTICAL INC. | Abandoned -- Failure to Respond to an Office Action | US20230241187A1 | Jonathan LeBowitz John Maga | United States United States | ALLEN, MARIANNE P |
| 2022-06-01 | 17829620 | Lysosomal Targeting Peptides and Uses Thereof | BIOMARIN PHARMACEUTICAL INC. | Abandoned -- Failure to Respond to an Office Action | US20220354934A1 | Jonathan LeBowitz John Maga | United States United States | ALLEN, MARIANNE P |
| 2022-05-23 | 17751144 | GLYCOLATE OXIDASE INHIBITORS FOR THE TREATMENT OF DISEASE | BIOMARIN PHARMACEUTICAL INC. | Abandoned -- Failure to Pay Issue Fee | US20230089374A1 | Bing WANG Qi CHAO | United States United States | RAHMANI, NILOOFAR |
| 2022-05-23 | 17751136 | GLYCOLATE OXIDASE INHIBITORS FOR THE TREATMENT OF DISEASE | BIOMARIN PHARMACEUTICAL INC. | Abandoned -- Failure to Pay Issue Fee | US20230079913A1 | Bing WANG Qi CHAO | United States United States | RAHMANI, NILOOFAR |
| 2022-05-18 | 17777690 | TREATMENT OF HEREDITARY ANGIOEDEMA WITH LIVER-SPECIFIC GENE THERAPY VECTORS | BIOMARIN PHARMACEUTICAL INC. | Abandoned -- Failure to Respond to an Office Action | US20230340078A1 | Peter COLOSI | United States | ALLEN, SARAH ELIZABETH |
| 2022-04-25 | 17771533 | SECONDARY CONTAINER WITH FLOW-THROUGH APERTURES FOR FREEZING, THAWING, AND SHIPPING PRODUCTS, AND ASSOCIATED METHODS | BIOMARIN PHARMACEUTICAL INC. | Abandoned -- Failure to Respond to an Office Action | US20220373249A1 | Richard WISNIEWSKI Saeed MOSHASHAEE Pooja SANE | United States United States United States | TEITELBAUM, DAVID J |
| 2022-04-25 | 17728359 | TARGETED THERAPEUTIC LYSOSOMAL ENZYME FUSION PROTEINS, ASSOCIATED FORMULATIONS AND USES THEREOF | BIOMARIN PHARMACEUTICAL INC. | Abandoned -- Failure to Respond to an Office Action | US20220251526A1 | SAEED MOSHASHAEE JASON K. PINKSTAFF ADAM SHAYWITZ NATALIE CIACCIO | United States United States United States United States | PAK, YONG D |
| 2022-02-15 | 17635488 | CHARACTERIZATION OF GENE THERAPY VIRAL PARTICLES USING SIZE EXCLUSION CHROMATOGRAPHY AND MULTI-ANGLE LIGHT SCATTERING TECHNOLOGIES | BIOMARIN PHARMACEUTICAL INC. | Abandoned -- Failure to Pay Issue Fee | US20220308022A1 | Vikas BHAT Geoffrey Yehuda BERGUIG Nicole Louise MCINTOSH | United States United States United States | CHESTNUT, BARRY A |
| 2022-01-10 | 17572018 | Targeted Therapeutic Lysosomal Enzyme Fusion Proteins and Uses Thereof | BioMarin Pharmaceutical Inc. | Abandoned -- Failure to Respond to an Office Action | US20220127326A1 | Mika Aoyagi-Scharber Teresa Margaret Christianson Melita Dvorak-Ewell Daniel J. Wendt Shinong Long Jonathan LeBowitz Daniel Solomon Gold | United States United States United States United States United States United States United States | RAMIREZ, DELIA M |
| 2021-12-16 | 17619818 | GLYCOLATE OXIDASE INHIBITORS FOR THE TREATMENT OF DISEASE | BIOMARIN PHARMACEUTICAL INC. | Expressly Abandoned -- During Examination | US20230088214A1 | Bing WANG Brett E. CRAWFORD Shripad BHAGWAT Xiaomei BAI | United States United States United States United States | CENTRAL, DOCKET |
| 2020-09-22 | 17028444 | HISTONE DEACETYLASE INHIBITORS | BIOMARIN PHARMACEUTICAL INC. | Abandoned -- Incomplete Application (Pre-examination) | US20210009519A1 | Shripad Bhagwat Gregory Luedtke Alexander Bridges | United States United States United States | |
| 2020-05-13 | 15931180 | METHODS OF REDOSING GENE THERAPY VECTORS | BIOMARIN PHARMACEUTICAL INC. | Abandoned -- Failure to Pay Issue Fee | US20200362368A1 | Peter COLOSI Justin ISHIDA Silvia RAMIREZ | United States United States United States | SALVOZA, M FRANCO G |
| 2020-05-08 | 16870851 | METHODS OF DIAGNOSING A DISEASE AND METHODS OF MONITORING TREATMENT OF A DISEASE BY QUANTIFYING A NON-REDUCING END GLYCAN RESIDUAL COMPOUND AND COMPARING TO A SECOND BIOMARKER | BIOMARIN PHARMACEUTICAL INC. | Abandoned -- Failure to Respond to an Office Action | US20210025874A1 | Brett E. CRAWFORD Jillian R. BROWN Charles A. GLASS Jim R. BEITEL Robin M. JACKMAN | United States United States United States United States United States | GITOMER, RALPH J |
| 2020-05-08 | 16869862 | Lysosomal Targeting Peptides and Uses Thereof | BioMarin Pharmaceutical Inc. | Abandoned -- Failure to Respond to an Office Action | US20210069304A1 | Jonathan LeBowitz John Maga | United States United States | ALLEN, MARIANNE P |
| 2020-05-04 | 16866397 | DETECTION OF OLIGOSACCHARIDES | BIOMARIN PHARMACEUTICAL INC. | Abandoned -- Failure to Respond to an Office Action | US20210017570A1 | Brett E. CRAWFORD Jillian R. BROWN Charles A. GLASS | United States United States United States | OLSON, ANDREA STEFFEL |
| 2019-11-08 | 16677954 | HISTONE DEACETYLASE INHIBITORS | BIOMARIN PHARMACEUTICAL INC. | Abandoned -- Failure to Respond to an Office Action | US20200148704A1 | Vincent Jacques James R. Rusche Norton P. Peet Jasbir Singh | United States United States United States United States | PATEL, SAGAR S |
| 2019-11-04 | 16610819 | IMPROVED LENTIVIRUSES FOR TRANSDUCTION OF HEMATOPOIETIC STEM CELLS | BIOMARIN PHARMACEUTICAL INC. | Abandoned -- Failure to Respond to an Office Action | US20210139932A1 | Michael Lochrie Wes Yonemoto Ramya Ankata Jac Michael | United States United States United States United States | NGUYEN, QUANG |
| 2019-08-22 | 16547730 | HDAC INHIBITORS | BIOMARIN PHARMACEUTICAL INC. | Abandoned -- Failure to Pay Issue Fee | US20190382351A1 | Vincent Jacques James R. Rusche | United States United States | SAEED, KAMAL A |
| 2019-06-20 | 16471628 | HISTONE DEACETYLASE INHIBITORS | BIOMARIN PHARMACEUTICAL INC. | Abandoned -- Failure to Respond to an Office Action | US20200087314A1 | Gregory Luedtke Shripad Bhagwat | United States United States | PATEL, SAGAR S |
| 2019-06-19 | 16471515 | CERAMIDE GALACTOSYLTRANSFERASE INHIBITORS FOR THE TREATMENT OF DISEASE | BioMarin Pharmaceutical Inc. | Abandoned -- Incomplete Application (Pre-examination) | US20190322676A1 | Bing WANG | United States | |
| 2019-05-14 | 16411841 | STABLE EXPRESSION OF AAV VECTORS IN JUVENILE SUBJECTS | BIOMARIN PHARMACEUTICAL INC. | Abandoned -- Failure to Respond to an Office Action | US20200069819A1 | Stuart Bunting | United States | MARVICH, MARIA |
| 2019-04-09 | 16379113 | Targeted Therapeutic Proteins | BioMarin Pharmaceutical Inc. | Abandoned -- Failure to Respond to an Office Action | US20190224282A1 | Jonathan LeBowitz Stephen M. Beverley | United States United States | GAMETT, DANIEL C |
| 2018-12-07 | 16308414 | CERAMIDE GALACTOSYLTRANSFERASE INHIBITORS FOR THE TREATMENT OF DISEASE | BioMarin Pharmaceutical Inc. | Abandoned -- Failure to Respond to an Office Action | US20190134005A1 | Bing Wang | United States | AGUIRRE, AMANDA L |
| 2018-05-08 | 15973986 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF METABOLIC DISORDERS | BIOMARIN PHARMACEUTICAL INC. | Abandoned -- Incomplete Application (Pre-examination) | US20180256582A1 | Daniel I. Oppenheimer Emil D. Kakkis Fredric D. Price Alejandro Dorenbaum Rudolf Moser Viola Groehn Thomas Egger Fritz Blatter | United States United States United States United States Switzerland Switzerland Switzerland Switzerland | |
| 2017-10-16 | 15566950 | METHODS FOR TREATING LYSOSOMAL STORAGE DISORDERS | BIOMARIN PHARMACEUTICAL INC. | Abandoned -- Incomplete Application (Pre-examination) | US20180092923A1 | Leonard Post Brett E. Crawford Shripad Bhagwat | United States United States United States | |
| 2017-04-07 | 15517814 | HEPARAN SULFATE BIOSYNTHESIS INHIBITORS FOR THE TREATMENT OF DISEASES | BioMarin Pharmaceutical Inc. | Abandoned -- Failure to Respond to an Office Action | US20190151312A1 | Shripad Bhagwat Bing Wang Gregory R. Luedtke Mark Spyvee | United States United States United States United States | PODGORSKI, DANIEL MICHAEL |
| 2016-10-24 | 15332793 | Variants of C-Type Natriuretic Peptide | BioMarin Pharmaceutical Inc. | Abandoned -- Failure to Respond to an Office Action | US20170051033A1 | Daniel J. Wendt Shinong Long Sianna Castillo Christopher P. Price Mika Aoyagi-Scharber Michel Claude Vellard Augustus O. Okhamafe | United States United States United States Germany United States United States United States | RAILEY, JOHNNY F |
| 2016-09-23 | 15274115 | Lysosomal Targeting Peptides and Uses Thereof | BIOMARIN PHARMACEUTICAL INC. | Abandoned -- Failure to Respond to an Office Action | US20170007680A1 | Jonathan LeBowitz John Maga | United States United States | ALLEN, MARIANNE P |
| 2016-07-15 | 15211180 | Use of Tetrahydrobiopterine Derivatives in the Treatment and Nutrition of Patients With Amino Acid Metabolic Disorders | BioMarin Pharmaceutical Inc. | Abandoned -- Failure to Respond to an Office Action | US20170042899A1 | Ania Muntau Adelbert A. Roscher | Germany Germany | SIMMONS, CHRIS E |
| 2016-05-06 | 15035193 | TRIAZOLE INTERMEDIATES USEFUL IN THE SYNTHESIS OF PROTECTED N-ALKYLTRIAZOLECARBALDEHYDES | BIOMARIN PHARMACEUTICAL INC. | Abandoned -- Failure to Pay Issue Fee | US20160280691A1 | Mark HENDERSON | United States | YOO, SUN JAE |
| 2016-04-06 | 15091813 | METHODS OF ADMINISTERING TETRAHYDROBIOPTERIN, ASSOCIATED COMPOSITIONS, AND METHODS OF MEASURING | BIOMARIN PHARMACEUTICAL INC. | Abandoned -- Failure to Respond to an Office Action | US20170000793A1 | Daniel I. Oppenheimer Alejandro Dorenbaum Augustus O. Okhamafe Erik Foehr Sianna Castillo Paul John Kostel | United States United States United States United States United States United States | CHONG, YONG SOO |
| 2015-11-20 | 14947482 | DRY BLEND FORMULATION OF TETRAHYDROBIOPTERIN | BioMarin Pharmaceutical Inc. | Abandoned -- Failure to Respond to an Office Action | US20160074406A1 | Tianwei Chou Augustus O. Okhamafe | United States United States | BROWN, COURTNEY A |
| 2015-03-17 | 14660488 | Variants of C-Type Natriuretic Peptide | BioMarin Pharmaceutical Inc. | Abandoned -- Failure to Respond to an Office Action | US20160256553A1 | Daniel J. Wendt Shinong Long Sianna Castillo Christopher P. Price Mika Aoyagi-Scharber Michel Claude Vellard Augustus O. Okhamafe | United States United States United States Germany United States United States United States | RAILEY, JOHNNY F |
| 2014-09-11 | 14483487 | TARGETED THERAPEUTIC PROTEINS | BIOMARIN PHARMACEUTICAL INC. | Abandoned -- Failure to Respond to an Office Action | US20150064183A1 | Jonathan LeBowitz Stephen M. Beverley | United States United States | GAMETT, DANIEL C |
| 2013-02-06 | 13760156 | METHODS OF ADMINISTERING TETRAHYDROBIOPTERIN, ASSOCIATED COMPOSITIONS, AND METHODS OF MEASURING | BIOMARIN PHARMACEUTICAL INC. | Abandoned -- Failure to Respond to an Office Action | US20130237543A1 | Daniel I. Oppenheimer Alejandro Dorenbaum Augustus O. Okhamafe Erik Foehr Sianna Castillo Paul John Kostel | United States United States United States United States United States United States | CHONG, YONG SOO |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |